An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 23 May 2013.
If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.
Please note that the information in the tables below is correct as at the date of the Patent Office Journal but is subject to change. Please check AUSPAT for the current status of any of the patents below.
Acceptance of the following patent applications has been opposed:
|2008306060||Beverage brewing unit||Nestec S.A.||Koninklijke Douwe Egberts B.V.|
Opposition to acceptance of the following applications has been withdrawn, and the application shall proceed to sealing:
|2004294810||In ovo vaccination of Campylobacter in avian species||Pfizer Products Inc.||Merial Ltd|
|2006226304||Process for microbial production of a valuable compound||DSM IP Assets B.V.||BASF SE|
|2009243527||Controlled release formulation||Euro-Celtique S.A.||Southern Cross Pharma Pty Ltd|
No additional opposition proceedings have been dismissed.
No additional applications have been withdrawn following opposition.
Extensions of Term of Standard Patents
The following applications for Extension of Term under Section 70 have been made:
|Patent No.||Title||Patentee(s)||First Reg Approval Date & Goods|
|2002231970||Mucoadhesive pharmaceutical formulations||GW Pharma Limited||26 Nov 2012For the goods SATIVEX nabiximols|
|2003253005||Cannabinoid liquid formulations for mucosal administration||GW Pharma Limited||26 Nov 2012For the goods SATIVEX nabiximols|
|2009202434||Cannabinoid liquid formulations for mucosal administration||GW Pharma Limited||26 Nov 2012For the goods SATIVEX nabiximols|
The following application(s) for Extension of Term have been accepted under Section 74. Notice of opposition under Section 75(1) to the undermentioned application(s) for an extension of term may be filed at the Patent Office within the prescribed time.
|Patent No.||Title||Patentee(s)||First Reg Approval Date & Goods||Address for Service|
|2003237886||C-aryl glucoside SGLT2 inhibitors and method||Bristol-Myers Squibb Company||22 Oct 2012For the goods FORXIGA dapagliflozin||Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000|
No additional applications for Extension of Term have been granted under Section 76.
Surrendered and Revoked Letters Patent
Surrendered Letters Patent
No patents have been offered for surrender.
Revocation of Letters Patent
No additional patents have been wholly or partially revoked.